Opinion|Videos|October 18, 2024
Improving Access to Lupus Nephritis Treatment: Strategies and Resources
Key Takeaways
- Financial constraints and limited healthcare access are significant barriers to timely lupus nephritis treatment, affecting patient outcomes.
- Patient assistance programs, educational initiatives, and support groups are crucial resources for facilitating access to lupus nephritis care.
Panelists discuss the challenges patients face in accessing lupus nephritis treatment and the resources available to support timely access, including how payers are facilitating care.
Advertisement
Episodes in this series
- What challenges or barriers do patients face when accessing lupus nephritis (LN) treatment, and what resources are available to support timely access to treatment?
- How are payers supporting timely access to care in LN?
Advertisement
Related to this article
The Autus Size-Adjustable Valve, which can be expanded as children grow, may reduce the need for repeat open-heart surgeries for congenital defects.
A scoping review of 15 studies found psoriasis prevalence markedly lower across 13 indigenous populations worldwide.
A traditional Medicare out-of-pocket (OOP) cap could reduce beneficiaries’ costs but increase annual federal spending by $39 billion to $96 billion.
A systemic sclerosis inception cohort and 17-study meta-analysis found a nearly 5-fold increase in lung cancer risk.
Medicare Advantage plans have varied motivations, strategies, and aspirations for addressing health-related social needs among home health beneficiaries, highlighting a need to expand the scope of supplemental benefits.
2026 Nobel Prize in Medicine honors optogenetics pioneers who turn algae light-sensing protein into neural switches, transforming brain mapping and enabling vision-restoration trials.
Medicare's Transforming Episode Accountability Model is projected to save $46.6 million by 2030, with safety-net hospitals potentially receiving the highest reconciliation payments.
A comparison of 2013 and 2022 data shows that cancer costs are not uniformly rising. Costs decreased for metastatic colorectal cancer but increased for both metastatic non–small cell lung cancer and multiple myeloma.
Advertisement
Advertisement
Trending on AJMC
1
Systemic Sclerosis Linked to Dramatic Rise in Lung Cancer Risk
2
FDA Approves First Heart Valve to Keep Pace With Children's Growth
3
Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer
4
Traditional Medicare OOP Cap Could Lower Costs, Raise Federal Spending
5